Leah M. Pyter
Neuroscience · The Ohio State University
Publications
105
Citations
2,189
Est. group size
~16
Recurring co-author estimate
Active years
40
Publishing since 1987
Leah M. Pyter studies how cancer and cancer treatments, particularly chemotherapy, affect the brain, behavior, and body, using both breast cancer patient studies and mouse models. Her work examines mechanisms such as gut microbiome disruption, inflammation, circadian rhythm disturbance, and hormonal changes to explain chemotherapy-related side effects like cognitive decline, anxiety, fatigue, and neuropathy. This research bridges neuroscience, oncology, immunology, and behavioral science, aiming to understand and potentially mitigate the neurological and psychological toll of cancer treatment.
Publication output has grown from a variable early period (2017-2021) to a more consistent, higher rate of roughly 7-8 papers per year since 2022, indicating steady and sustained research activity in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Gut Microbiota and Nutritional Profiles of Colon Cancer Patients Undergoing Chemotherapy: A Longitudinal Pilot Study
Nutrients · 2026
- Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients
Psychoneuroendocrinology · 2026
- Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and pain
Brain Behavior and Immunity · 2026
- A systematic assessment of the short- and long-term effects of commonly used breast cancer chemotherapeutics on the gut microbiome‒blood‒brain axis of female mice
Gut Microbes · 2026
- Mechanistic insights into chemotherapy-induced circadian disruption using rodent models
Trends in Neurosciences · 2025
- The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancer
Psychoneuroendocrinology · 2025
- Paclitaxel Chemotherapy Disrupts Circadian Gene Transcription and Function of the Suprachiasmatic Nuclei in Female Mice
eNeuro · 2025
- Strain-dependent neuronal disposition and toxicity of paclitaxel in mice
ASPET Discovery · 2025
- Effect of Intolerance of Uncertainty on Perceived Cognitive Function Among Breast Cancer Patients Before Chemotherapy
Cancers · 2025
- Spinal Cord Injury Disrupts Inflammatory Signaling and Impairs Skin Wound Healing: Evidence from Two Models of Decubitus Ulcers
Journal of Neurotrauma · 2025
- Characterization of a Monogamous California Mouse Model of Chemotherapy
eNeuro · 2025
- Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
Brain Behavior and Immunity · 2024
- Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer
npj Breast Cancer · 2024
- Microglia contribute to mammary tumor‐induced neuroinflammation in a female mouse model
The FASEB Journal · 2024
- Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice
Gut Microbes · 2024
- Brain Behavior and Immunity×25
- Scientific Reports×3
- Behavioural Brain Research×2
- Gut Microbes×2
- Psychoneuroendocrinology×2
- K.R. Jordan
Neuroscience · The Ohio State University
- Annelise A. Madison
Neuroscience · The Ohio State University
- Tamar Gur
Neuroscience · The Ohio State University
- Micah Iticovici
Neuroscience · Indiana University
- Alexander B. Niculescu
Neuroscience · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile